TCT 2022: Edwards Ready To Take On Abbott In Mitral Repair Market With ‘Premium’ Device

 
• By Reed Miller

Edwards Lifesciences is ramping up US commercialization of its Pascal Precision mitral valve transcatheter edge-to-edge repair device, the first US competitor for Abbott’s MitraClip. The FDA approved Pascal Precision earlier than the company expected, based on results of the CLASP IID trial.

Edwards Lifesciences' Pascal M TEER clip
• Source: Edwards Lifesciences

More from Approvals

More from Policy & Regulation